JDOC

JPMorgan Healthcare Leaders ETF

$57.29
+0.00%
Market closed. Last update: 12:37 PM ET

📎 Investment Objective

The JPMorgan Healthcare Leaders ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Morningstar US Healthcare Leaders Index.

Overview

ETF tracking JPMorgan Healthcare Leaders ETF

Category Healthcare
Issuer Other
Inception Date 2023-11-02
Market Cap $8.6M
Average Volume N/A
Dividend Yield 4.92%
52-Week Range $47.67 - $57.56
VWAP $57.32

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The JPMorgan Healthcare Leaders ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Morningstar US Healthcare Leaders Index.

🎯 Investment Strategy

The ETF invests primarily in equity securities of companies in the healthcare sector that are included in the underlying index. The index is designed to provide exposure to large-cap and mid-cap U.S. healthcare companies that exhibit attractive valuation, strong growth, and positive sentiment.

✨ Key Features

  • Provides broad exposure to the U.S. healthcare sector
  • Focuses on large-cap and mid-cap companies with attractive fundamentals
  • Passively managed to track the performance of the underlying index
  • Low expense ratio of 0.00%

⚠️ Primary Risks

  • Concentration risk as the fund is focused on the healthcare sector
  • Market risk as the value of the fund's holdings may fluctuate with the overall stock market
  • Liquidity risk as some of the fund's holdings may have limited trading volume
  • Tracking error risk as the fund may not perfectly replicate the performance of the underlying index

👤 Best For

The JPMorgan Healthcare Leaders ETF may be suitable for investors seeking broad exposure to the U.S. healthcare sector with a focus on large-cap and mid-cap companies with attractive fundamentals. It may be appropriate for investors with a medium to long-term investment horizon and a moderate to high-risk tolerance.